We report a paradoxical contribution of the differentiation signal to genomic instability and aggressiveness of squamous cancer (SCC).
https://www.nature.com/cddis/journal/v8/n6/full/cddis2017259a.html
Inefficient differentiation response to cell cycle stress leads to genomic instability and malignant progression of squamous carcinoma cells
Pilar Alonso-Lecue1,11, Isabel de Pedro1,11, Vincent Coulon2, Rut Molinuevo1, Corina Lorz3, Carmen Segrelles3, Laura Ceballos1, Daniel López-Aventín4, Ana García-Valtuille5, José M Bernal1,6, Francisco Mazorra5,7, Ramón M Pujol4,8, Jesús Paramio3, J Ramón Sanz1,5,9, Ana Freije1, Agustí Toll4,8 and Alberto Gandarillas1,10
Abstract
Squamous cell carcinoma (SCC) or
epidermoid cancer is a frequent and aggressive malignancy. However in
apparent paradox it retains the squamous differentiation phenotype
except for very dysplastic lesions. We have shown that cell cycle stress
in normal epidermal keratinocytes triggers a squamous differentiation
response involving irreversible mitosis block and polyploidisation. Here
we show that cutaneous SCC cells conserve a partial squamous DNA
damage-induced differentiation response that allows them to overcome the
cell division block. The capacity to divide in spite of drug-induced
mitotic stress and DNA damage made well-differentiated SCC cells more
genomically instable and more malignant in vivo. Consistently, in
a series of human biopsies, non-metastatic SCCs displayed a higher
degree of chromosomal alterations and higher expression of the S phase
regulator Cyclin E and the DNA damage signal γH2AX than the less aggressive, non-squamous, basal cell carcinomas. However, metastatic SCCs lost the γH2AX
signal and Cyclin E, or accumulated cytoplasmic Cyclin E. Conversely,
inhibition of endogenous Cyclin E in well-differentiated SCC cells
interfered with the squamous phenotype. The results suggest a dual role
of cell cycle stress-induced differentiation in squamous cancer: the
resulting mitotic blocks would impose, when irreversible, a
proliferative barrier, when reversible, a source of genomic instability,
thus contributing to malignancy.
No comments:
Post a Comment